INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

76,653 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
SR
Sotomayor RafaelCEO & President
NXPINXP Semiconductors N.V.
Tax withholding
F$92K
400 sh
Apr 29, 2026May 1, 2026
Page 1028 of 1917
← PrevNext →
traded Apr 29, 2026
+2d
SEC Form 4

Evidence

12
RS
Rubenstein SarahEVP AND CFO
CWENClearway Energy, Inc.
Other acquisition or disposition
J—
380 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

11
RK
Ross KadeChief Information Officer
BANDBandwidth Inc.
Open-market sale · 10b5-1 plan
SELL$46K
1,400 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
WM
Weakley MonicaDirector
EXPIAGNT, Inc.
Option exercise
M—
320 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
SP
Sharma PankajChief Business Officer
RELYRemitly Global, Inc.
Grant or award
A—
118.4K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
DA
Davis Seth AnthonyVICE PRESIDENT, CONTROLLER
RLIRLI CORP
Option exercise
M—
3,000 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
MF
Miller Michael FrancisChief Operating Officer
QTRXQuanterix Corp
Option exercise
M—
130 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
PJ
Paulson JohnDirector
BLCOBausch & Lomb Corp
Grant or award
A$22K
1,375 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
DC
Dundas Ian CDirector
CHRDChord Energy Corp
Grant or award
A—
1,524 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
AB
Albert BenjaminDirector, CEO
HCATHealth Catalyst, Inc.
Tax withholding
F$417
310 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
SA
Smith Ryan AEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,647
138 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
FA
Forbes AndrewEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,092
127 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
FL
Fu LuyangSr. VP, Chief Actuary - Sub
CINFCINCINNATI FINANCIAL CORP
Tax withholding
F$24K
147 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
RB
Raths BarbaraEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$5,010
104 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
MM
McGrath Christine MontenegroDirector
REYNReynolds Consumer Products Inc.
Grant or award
A—
7,539 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
CE
Ching Michael E.Director
PRIMPrimoris Services Corp
Grant or award
A—
268 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
AR
Archer Michael REVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$7,370
153 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
AD
Ackley DavidEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,284
131 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
AR
Archer Michael REVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$8,826
184 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
MS
McKinney SamanthaDirector
CHRDChord Energy Corp
Grant or award
A—
1,524 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
AB
Albert BenjaminDirector, CEO
HCATHealth Catalyst, Inc.
Grant or award
A—
1,124 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
SK
Snyder KristenDirector
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
8,418 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
MH
Martel William HEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,551
136 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
ME
Mily ElizabethDirector
SOLVSolventum Corp
Option exercise
M—
3,403 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
HS
Hackman Jeffrey S.Director, Chief Executive Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
1,159 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
RC
Robertson Russel CDirector
BLCOBausch & Lomb Corp
Grant or award
A$26K
1,611 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
GS
Griffiths SimonCEO
CACCAMDEN NATIONAL CORP
Tax withholding
F$37K
776 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
PD
Poillon DianeDirector
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
1,928 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
MG
McKnight GarrettEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,524
136 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
MG
McKnight GarrettEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$5,058
105 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
MF
Miller Michael FrancisChief Operating Officer
QTRXQuanterix Corp
Tax withholding
F$122
39 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
168 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
TC
Tarvin Landon CPresident,UFP Retail Solutions
UFPIUFP INDUSTRIES INC
Grant or award
A$1,163
13 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
GS
Griffiths SimonCEO
CACCAMDEN NATIONAL CORP
Tax withholding
F$40K
824 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
WM
Weakley MonicaDirector
EXPIAGNT, Inc.
Grant or award
A$2,356
414 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$190K
7,500 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
RB
Raths BarbaraEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,284
131 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
155 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
PD
Poillon DianeDirector
BHRBBurke & Herbert Financial Services Corp.
Grant or award
A—
675 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
EA
Edwards Shirley AnnDirector
SOLVSolventum Corp
Option exercise
M—
3,403 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence